🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
68.45
+0.73 (1.08%)
At close: Nov 20, 2026, 4:00 PM EST
67.65
-0.80 (-1.17%)
After-hours: Nov 20, 2026, 7:48 PM EST

Royalty Pharma Revenue

Royalty Pharma had revenue of $690.10M in the quarter ending September 30, 2026, with 13.26% growth. This brings the company's total for the last twelve months to $2.62B, up 11.36% year-over-year. In the year 2025, Royalty Pharma had annual revenue of $2.38B with 5.06% growth. That makes Royalty Pharma the 4,191st largest company in the world by revenue and 1,145th in the United States.

Revenue (ttm)
$2.62B
Revenue Growth
+11.36%
P/S Ratio
15.00
Revenue / Employee
$26,168,100
Employees
100
Market Cap
39.26B

Revenue Chart

Revenue by Segment

  • Cystic Fibrosis Franchise 828.18M 34.8%
  • Other Products 647.67M 27.2%
  • Evrysdi 206.97M 8.7%
  • Voranigo 154.42M 6.5%
  • Trelegy 154.10M 6.5%
  • Tremfya 152.94M 6.4%
  • Other Royalty Income and 117.04M 4.9%
  • Tysabri 116.88M 4.9%
Fiscal year ended Dec 31, 2025 See the full Royalty Pharma breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.38B114.62M5.06%
Dec 31, 20242.26B-90.98M-3.86%
Dec 31, 20232.35B117.34M5.24%
Dec 31, 20222.24B-52.25M-2.28%
Dec 31, 20212.29B167.11M7.87%
Dec 31, 20202.12B308.10M16.98%
Dec 31, 20191.81B19.36M1.08%
Dec 31, 20181.79B196.96M12.33%
Dec 31, 20171.60B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
BeOne Medicines AG6.45B
Incyte6.01B
argenx SE5.92B
Alnylam Pharmaceuticals5.01B
Genmab4.30B
BioNTech SE2.75B
Moderna2.53B
Insmed1.52B
Revenue Rankings